Computer Screen Properties Study

Sponsor
NYU Langone Health (Other)
Overall Status
Recruiting
CT.gov ID
NCT05042960
Collaborator
(none)
120
1
3
11.5
10.4

Study Details

Study Description

Brief Summary

The purpose of this study is to identify how various popular methods of changing computer screen settings affect dry eye symptoms (eye pain, grittiness, tearing, burning, etc.). Specifically, this study will examine if there are differences in effects of blue light blocking (F.lux app or night shift) versus reducing screen brightness on the symptoms of dry eye.

Condition or Disease Intervention/Treatment Phase
  • Other: Brightness
N/A

Detailed Description

After the initial survey, participants will be randomized by a randomization tool internal to Redcap to be in one of three arms of intervention: no intervention, screen brightness reduction to 50%, and tone modulator application. Instructions will be e-mailed to participants to explain the steps they must take depending on which treatment arm they are randomized to. Adherence will be monitored and assessed at the time of post-intervention survey. If participants have issues with the software of complying, they will be able to contact the research team at any point.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Investigating the Effects of Screen Brightness and Warm Tone Modulation on Dry Eye Symptoms
Actual Study Start Date :
Sep 15, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: 50% brightness group

Participants will be using a computer screen reducing screen brightness 50%.

Other: Brightness
Changing the colors or brightness on the device (computer screen) for one month

Experimental: Light App group

Participants in this group will use a modulating computer screen tone with flux or night shift app.

Other: Brightness
Changing the colors or brightness on the device (computer screen) for one month

No Intervention: Control group

Participants in this group will be a control with no change in screen features

Outcome Measures

Primary Outcome Measures

  1. The frequency of dry eye symptoms [Day 1]

    Participants will complete a pre-intervention survey to measure the frequency of dry eye symptoms.

  2. The frequency of dry eye symptoms [Day 30]

    Participants will complete a post-intervention survey to measure the frequency of dry eye symptoms.

  3. The severity of dry eye symptoms [Day 1]

    Participants will complete a pre-intervention survey to measure the severity of dry eye symptoms.

  4. The severity of dry eye symptoms [Day 30]

    Participants will complete a post-intervention survey to measure the severity of dry eye symptoms.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult person (18+) with intact vision who uses computers
Exclusion Criteria:
  • Children (<18 years)

  • Adult person without intact vision

  • Adult who does not use computer screens

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU Langone Health New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Leela Raju, MD, NYU Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT05042960
Other Study ID Numbers:
  • 21-00472
First Posted:
Sep 13, 2021
Last Update Posted:
Aug 9, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2022